Insufficient scRNA-seq data for expression of IL17RD at single-cell level.
Insufficient scRNA-seq data for expression of IL17RD at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 1035.80 | 2607 / 2642 | 100% | 26.37 | 702 / 705 |
ovary | 100% | 2394.02 | 180 / 180 | 84% | 12.19 | 363 / 430 |
breast | 96% | 1843.56 | 440 / 459 | 87% | 12.84 | 978 / 1118 |
prostate | 98% | 1163.95 | 240 / 245 | 85% | 6.50 | 426 / 502 |
kidney | 100% | 933.52 | 89 / 89 | 75% | 10.29 | 680 / 901 |
uterus | 99% | 5109.53 | 168 / 170 | 61% | 10.63 | 279 / 459 |
skin | 92% | 511.15 | 1659 / 1809 | 53% | 9.58 | 249 / 472 |
esophagus | 96% | 693.83 | 1392 / 1445 | 45% | 4.36 | 83 / 183 |
bladder | 95% | 1206.43 | 20 / 21 | 36% | 2.66 | 182 / 504 |
intestine | 79% | 1545.03 | 759 / 966 | 44% | 3.94 | 232 / 527 |
thymus | 51% | 187.45 | 330 / 653 | 59% | 4.74 | 358 / 605 |
spleen | 93% | 639.25 | 224 / 241 | 0% | 0 | 0 / 0 |
adipose | 93% | 787.63 | 1115 / 1204 | 0% | 0 | 0 / 0 |
stomach | 44% | 456.43 | 158 / 359 | 41% | 3.41 | 116 / 286 |
blood vessel | 83% | 497.30 | 1110 / 1335 | 0% | 0 | 0 / 0 |
heart | 77% | 368.75 | 660 / 861 | 0% | 0 | 0 / 0 |
lung | 35% | 127.78 | 205 / 578 | 39% | 2.99 | 446 / 1155 |
pancreas | 20% | 58.44 | 66 / 328 | 51% | 2.47 | 90 / 178 |
adrenal gland | 12% | 33.90 | 31 / 258 | 36% | 2.77 | 82 / 230 |
tonsil | 0% | 0 | 0 / 0 | 40% | 2.70 | 18 / 45 |
muscle | 13% | 45.77 | 106 / 803 | 0% | 0 | 0 / 0 |
liver | 0% | 0.96 | 1 / 226 | 4% | 0.24 | 15 / 406 |
eye | 0% | 0 | 0 / 0 | 4% | 0.14 | 3 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0010719 | Biological process | negative regulation of epithelial to mesenchymal transition |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0030368 | Molecular function | interleukin-17 receptor activity |
Gene name | IL17RD |
Protein name | Interleukin 17 receptor D Interleukin-17 receptor D (IL-17 receptor D) (IL-17RD) (IL17Rhom) (Interleukin-17 receptor-like protein) (Sef homolog) (hSef) |
Synonyms | SEF IL17RLM UNQ6115/PRO20026 |
Description | FUNCTION: Feedback inhibitor of fibroblast growth factor mediated Ras-MAPK signaling and ERK activation . Regulates the nuclear ERK signaling pathway by spatially blocking nuclear translocation of activated ERK without inhibiting cytoplasmic phosphorylation of ERK . Mediates JNK activation and may be involved in apoptosis (By similarity). May inhibit FGF-induced FGFR1 tyrosine phosphorylation (By similarity). Might have a role in the early stages of fate specification of GnRH-secreting neurons (By similarity). Inhibits TGFB-induced epithelial-to-mesenchymal transition in lens epithelial cells (By similarity). . |
Accessions | ENST00000467210.5 ENST00000296318.12 [Q8NFM7-1] ENST00000320057.9 [Q8NFM7-2] Q8NFM7 ENST00000463523.5 [Q8NFM7-2] C9J6R0 |